Everest Medicines Statistics

Total Valuation

Everest Medicines has a market cap or net worth of HKD 11.30 billion. The enterprise value is 9.34 billion.

Market Cap	11.30B
Enterprise Value	9.34B

Important Dates

The next estimated earnings date is Wednesday, November 27, 2024.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	n/a

Share Statistics

Everest Medicines has 321.55 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	321.55M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.96%
Owned by Institutions (%)	11.51%
Float	186.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.25
EV / Sales	20.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-45.28

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	1.04M
Profits Per Employee	-2.62M
Employee Count	432
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.32% in the last 52 weeks. The beta is 2.09, so Everest Medicines's price volatility has been higher than the market average.

Beta (5Y)	2.09
52-Week Price Change	+31.32%
50-Day Moving Average	28.00
200-Day Moving Average	23.02
Relative Strength Index (RSI)	61.69
Average Volume (20 Days)	5,683,910

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Everest Medicines had revenue of HKD 449.73 million and -1.13 billion in losses.

Revenue	449.73M
Gross Profit	340.64M
Operating Income	-1.12B
Pretax Income	-1.13B
Net Income	-1.13B
EBITDA	-1.07B
EBIT	-1.12B
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.74%, with operating and profit margins of -249.45% and -251.64%.

Gross Margin	75.74%
Operating Margin	-249.45%
Pretax Margin	-251.64%
Profit Margin	-251.64%
EBITDA Margin	-237.72%
EBIT Margin	-249.45%
FCF Margin	n/a

Dividends & Yields

Everest Medicines does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a